Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy

BACKGROUND: Results from phase III clinical trial CheckMate 025 have established nivolumab as the standard of care for treatment of metastatic renal-cell carcinoma (mRCC) after VEGF inhibitor failure; however, elderly patients are under-represented in the registration trial and little is known about...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Vitale, Maria Giuseppa, Scagliarini, Sarah, Galli, Luca, Pignata, Sandro, Lo Re, Giovanni, Berruti, Alfredo, Defferrari, Carlotta, Spada, Massimiliano, Masini, Cristina, Santini, Daniele, Ciuffreda, Libero, Ruggeri, Enzo Maria, Bengala, Carmelo, Livi, Lorenzo, Fagnani, Daniele, Bonetti, Andrea, Giustini, Lucio, Hamzaj, Alketa, Procopio, Giuseppe, Caserta, Claudia, Sabbatini, Roberto
التنسيق: Online مقال نص
اللغة:English
منشور في: Public Library of Science 2018
الموضوعات:
Research Article
الوصول للمادة أونلاين:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034807/
https://www.ncbi.nlm.nih.gov/pubmed/29979712
http://dx.doi.org/10.1371/journal.pone.0199642

الانترنت

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034807/
https://www.ncbi.nlm.nih.gov/pubmed/29979712
http://dx.doi.org/10.1371/journal.pone.0199642

مواد مشابهة